Clinical Trials Logo
  1. Home
  2. Infection Viral
  3. NCT05041764
  4. Details
NCT05041764 Clinical Trial

RNA Sequencing of Individual Versus Wastewater - SARS-CoV2

Infection Viral Clinical Trial

— Cagablea  

Official title:
A Comparison Between Individual and Wastewater SARS-CoV2 RNA Sequencing

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05041764
Other study ID # 21DSP-IPMC01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 1, 2020
Est. completion date November 1, 2020

Study information
Verified date September 2021
Source Centre Hospitalier Universitaire de Nice
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim is to compare the percentage of the different SARS-CoV2 lineages that are detected in wastewater samples with matched clinical samples. About 1,400 swab samples from patients living in Nice were tested by Biogroup between Oct 19th and Oct 23rd (Week 43 of 2020). The sequence of 81 PCR positive samples, corresponding to all samples that were unambiguously assigned to one of the wastewater catchment areas and their lineage was determined. These values were compared to values measured in wastewater.

Recruitment information / eligibility
Status Completed
Enrollment 1409
Est. completion date November 1, 2020
Est. primary completion date November 1, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - whole population tested in Nice during W43 of 2020 Exclusion Criteria: - none

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• NO INTERVENTION
No INTERVENTION

Locations
Country Name City State
France Nice Hospital Nice
France Ipmc . Cnrs Sophia Antipolis

Sponsors (2)
Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice Centre National de la Recherche Scientifique, France

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary RTqPCR result positive ou negative result to SAR-Cov2 1 month
Primary SARS-CoV2 sequence analyse of SARS-CoV2 sequence (in the case of positive samples) 1 month
See also
  Status Clinical Trial Phase
Recruiting NCT06178822 - Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Completed NCT04239521 - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Recruiting NCT03818334 - Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies Phase 2/Phase 3
Completed NCT04637867 - COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO) N/A
Recruiting NCT06149494 - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Phase 2
Completed NCT05069623 - A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers Phase 1/Phase 2
Recruiting NCT04386460 - Covid-19 and Prevention of Malnutrition After Confinement by Dentists
Completed NCT04290780 - COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus
Completed NCT04327180 - PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
Recruiting NCT04438629 - Evaluation of Immune Response in COVID-19 Patients
Active, not recruiting NCT05874713 - Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults Phase 2
Completed NCT03163628 - biomArkers to differeNtiate bacTerial From vIral iNfEctions N/A
Completed NCT04924842 - COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2)
Completed NCT04354155 - COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial Phase 2
Recruiting NCT05875961 - Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults Phase 1
Recruiting NCT06379061 - Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
Active, not recruiting NCT04481529 - COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector
Recruiting NCT05090319 - Micro-hematology Analyzer for Viral/Bacterial Description
Not yet recruiting NCT04887233 - Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19) N/A
Completed NCT04754633 - Comparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI Guidelines